Home › Longkanker › Michigan › Canton
Longkanker klinische studies in Canton, MI
9 studies voor Longkanker zoeken deelnemers op locaties in en rond Canton (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RekruterenFase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekruterenFase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruterenFase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruterenGezonde vrijwilligers welkom
- Henry Ford Medical Center - Plymouth, Plymouth · 4 mijl verwijderd
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Longkanker studies in andere steden
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Arlington, VA41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Andere studies in Canton
- Niet-kleincellige longkanker8 studies
- Prostaatkanker8 studies
- Acute myeloïde leukemie7 studies
- Colorectale kanker6 studies
- Nierkanker (niercelcarcinoom)5 studies
- Eierstokkanker4 studies
- Borstkanker4 studies
- Blasenkanker4 studies
- Plaveiselcelcarcinoom van hoofd en hals3 studies
- Hypopharynxkanker3 studies
- Keelholtekanker3 studies
- Mondkanker3 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.